What You Should Know:
- Cellino, a Cambridge, MA-based personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the closing of a $16M Seed financing round. The round was co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC.
- The company’s platform solves a time-consuming, major bottleneck of developing drugs that rely on cell therapy, having to
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Mammoth Biosciences, Agilent Partner on High-Throughput CRISPR-Based SARS-CoV-2 Diagnostic Test
What You Should Know:
- Mammoth Biosciences, the company bringing CRISPR out of the lab to help fight COVID-19 announced a partnership with lab giant Agilent to automate and scale its CRISPR-based high throughput testing system.
- Building on existing partnerships with Hamilton and Merck, this deal will help deliver a workflow capable of performing more than 4,000 COVID-19 tests per day.
Mammoth Biosciences, Inc. today announced a co-marketing agreement with Agilent Technologies to
Read More
AstraZeneca and Care Access Research Collaborate on Decentralized COVID-19 Clinical Trial
What You Should Know:
- AstraZeneca and Care Access Research are teaming up to
provide decentralized, mobile research site operations for AstraZeneca’s
AZD7442 phase III clinical trial in the US.
- The Phase III clinical trial called STORM CHASER will
assess the safety and efficacy of AZD7442 for post-exposure prophylaxis and
pre-emptive treatment in approximately 1,125 participants in the US and UK.
Care Access Research, a decentralized research organization
(DRO) that operates as
Read More
West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution
What You Should Know:
- West Virginians will now have access to a COVID-19
vaccination pre-registration tool available statewide.
- West Virginia is the first state in the nation to deploy this new system through Everbridge, a global provider of critical event management technologies. The tool enables West Virginians to pre-register for COVID-19 vaccination and receive updates through text, phone, and/or email.
President Joe Biden has made it his priority to tackle COVID-19
Read More
Therma Fisher Acquires Rapid COVID-19 Test Provider Mesa Biotech for $450M
What You Should Know:
- Thermo
Fisher Scientific Inc. has entered into a definitive agreement to acquire
Mesa Biotech, Inc., a San Diego,
CA-based molecular diagnostic company, for approximately $450 million in cash.
Under the terms of the agreement, Thermo Fisher will pay up to an additional
$100 million in cash upon the completion of certain milestones following the
close of the transaction.
- Mesa Biotech designs, develops, manufactures, and commercializes next generation Rapid PCR
Read More
87% of Americans Want to Receive COVID-19 Vaccine Information From Their Providers
What You Should Know:
According to a recent Updox survey, 87% of Americans say
they want to receive information from their healthcare provider on COVID-19
vaccine-related news/updates, with their healthcare providers cited as the most
trusted source on the topic (34%) -- behind health protection agencies (32%),
government entities (9%), and the biotechnology companies developing the
vaccines (4%).
When it comes to means of communication with their
healthcare provider, consumers’
Read More
Uber, Moderna Partner to Increase Access to COVID-19 Vaccines
What You Should Know:
- Moderna and Uber announced a partnership to work together initially to provide accessible, credible information on COVID-19 vaccine safety through Uber’s in-app messaging.
- The two companies will also work with public health and
other organizations to identify additional opportunities to support ongoing
efforts to broaden access to COVID-19
vaccines.
- Additional options being evaluated include incorporating
ride scheduling directly into the immunization
Read More
CVS Health to Provide In-Home Chemotherapy with Cancer Treatment Centers of America
What You Should Know:
- Today, CVS Health announced a collaboration with Cancer
Treatment Centers of America (CTCA) to provide in-home chemotherapy for
clinically eligible and fully insured patients.
- The program, which leverages CVS Health’s home infusion
service, Coram, and CTCA’s expertise as a top oncology care provider, aims to
minimize immunocompromised patients’ exposure to COVID-19 by offering an
alternative to inpatient or in-office cancer care.
- Through this program,
Read More
Komodo Health Acquires Cloud-Based Life Sciences Platform Mavens- M&A
What You Should Know:
- Komodo Health announces the acquisition of Mavens, a cloud-based platform for life sciences to expand its software capabilities.
- The acquisition of Mavens offers customers a cloud-based platform with a suite of software that ends reliance on fragmented data and expensive single-point solutions.
Komodo Health today announced its acquisition of Mavens, a leader in cloud-based technology solutions for the life sciences. The acquisition will enable Komodo
Read More
Verily, Broad, Microsoft Partner to Expand Life Sciences Research with Azure Cloud
What You Should Know:
- Verily and The Broad Institute have partnered with
Microsoft to expand health and life sciences research utilizing the Microsoft
Azure cloud.
- The new partnership brings together Microsoft’s cloud, data, and AI technologies, and a global network of more than 168,000 health and life sciences partners to accelerate the development of global biomedical research through the Terra platform, provide greater access and empower the open-source community.
Broad
Read More
